Home > Financial Ratios > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

AKUMS DRUGS & PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 12.981.551.08-3.900.10

What is the latest EV/Core EBITDA ratio of AKUMS DRUGS & PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of AKUMS DRUGS & PHARMACEUTICALS is 12.98 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202512.98
Mar20241.55
Mar20231.08
Mar2022-3.90
Mar20210.10

How is EV/Core EBITDA of AKUMS DRUGS & PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 12.98
737.42
Mar2024 1.55
43.52
Mar2023 1.08
Positive
Mar2022 -3.9
Negative
Mar2021 0.1 -

Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of AKUMS DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS ₹7,035.0 Cr 2.2% -1.8% -21.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AKUMS DRUGS & PHARMACEUTICALS

2.2%

-1.8%

-21.8%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses